Sequencing Technology

Qiagen believes it has gained access to a relatively simple and inexpensive technology to bolster its offerings in the growing single-cell molecular biology market.

Birmingham Women's NHS Foundation Trust said it is partnering with Illumina to develop an NIPT, which it hopes to start offering in September.

Using a combination of approaches, researchers characterized influenza A viruses at two live animal swine markets in Minnesota.

Encoded Genomics, EpiBiome, and Xcell Biosciences are the first graduates of Illumina's program which supports early-stage firms working on NGS applications.

Sequences from golden jackals, wolves, and other canines suggest the Africa's golden jackal is not part of the same species as golden jackals in Eurasia.

Direct sensing bioFETs and methods of manufacture
Pen-shaped device for biological sample preparation and analysis
Devices and methods for biological sample preparation
Methods for treating infection involving identification of a carbapanemase gene
Artificial DNA sequence with optimized leader function in 5' (5'-UTR) for the improved expression of heterologous proteins in plants
Methods and compositions for amplification of nucleic acids

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Oct
15
Sponsored by
Parabase

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.